Hope in a Dose: CGT Podcast | Ep. 3 | Partners in Scale: CDMOs and CROs Working as One

Host: Louise Kearney, Head of Cell and Gene Therapy, Strategy and Delivery at FortreaParticipants:  Jan Skoumal, Head of Delivery for Oncology, Fortrea  Ludek Sojka, CEO, SCT BioDescription: In this episode we will discuss topics that are critical to the success of CGT programs: seamless collaboration between CDMOs and CROs. In cell and gene therapy, complexity isn't just in science, it's in the execution. And that's where integrative thinking comes in, where manufacturing and clinical operations work as one, we can accelerate timelines, reduce risk, and optimize costs. In this episode, we'll explore how early alignment between CDMOs and CROs can transform technologies into opportunities, from protocol design to study chain logistics and overall project success. Learn how proactive coordination—from tech transfer and manufacturing to clinical operations and regulatory submissions—creates a unified strategy that drives success. Hear real-world insights on overcoming challenges, synchronizing supply chains, and delivering hope to patients faster through true partnership.